默克公司的一款眼部疾病药物在临床试验中达到了主要目标

路透中文
Sep 24
默克公司的一款眼部疾病药物在临床试验中达到了主要目标

路透9月24日 - 默克公司 MRK.N 周四表示,其研发的药物在一项针对患有某种影响眼底血管疾病的成人患者的中后期临床试验中,达到了主要研究目标。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10